SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 91 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2015. The put-call ratio across all filers is 2.10 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,000 | +150.0% | 19,439 | +113.6% | 0.00% | – |
| Q1 2016 | $2,000 | -86.7% | 9,100 | -79.3% | 0.00% | – |
| Q4 2015 | $15,000 | -72.2% | 43,989 | +40.5% | 0.00% | – |
| Q3 2015 | $54,000 | -15.6% | 31,306 | +8.3% | 0.00% | – |
| Q2 2015 | $64,000 | -28.1% | 28,900 | -36.9% | 0.00% | – |
| Q1 2015 | $89,000 | -46.1% | 45,800 | -26.2% | 0.00% | – |
| Q4 2014 | $165,000 | – | 62,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
| Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
| NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
| Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
| SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
| Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
| Roundview Capital LLC | 21,100 | $91,000 | 0.04% |